Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA to Hold Workshop on Developing Drugs for Female Sex Problems
WSJ Pharmalot
Thursday, August 14, 2014 - 10:13am
tags:
FDA, female sexual dysfunction
Most Popular News Headlines For Wednesday, August 13 2014
CP Wire
Thursday, August 14, 2014 - 10:11am
tags:
Pfizer, Bristol-Myers Squibb, Eliquis, Belsomra, insomnia, Kyprolis, Aranesp, Amgen, InterMune, Sanofi, Roche
Prefer a Swiss tax rate? Basilea chief says he's ready to parley
Fierce Biotech
Thursday, August 14, 2014 - 9:41am
tags:
Switzerland, Basilea, M&A
AbbVie makes inroads in orphan drugs
Medical Marketing and Media
Thursday, August 14, 2014 - 8:45am
tags:
AbbVie, orphan drugs, glioblastoma multiforme, ABT-414
Why Amgen, Inc.’s Kyprolis FOCUS Failure Is a Big Deal
Motley Fool
Thursday, August 14, 2014 - 8:43am
tags:
Amgen, Kyprolis, Multiple Myeloma
Allergan Acquires LiRIS® Program from TARIS Biomedical
Yahoo
Thursday, August 14, 2014 - 8:36am
tags:
Allergan, LiRIS, Taris, Interstitial Cystitis
Tekmira says discussing Ebola treatment with governments, NGOs
Yahoo/Reuters
Thursday, August 14, 2014 - 8:22am
tags:
ebola virus, NGOs, Tekmira, TKM-EBOLA
AstraZeneca starts final-stage tests on severe asthma drug
Yahoo/Reuters
Thursday, August 14, 2014 - 8:17am
tags:
asthma, AstraZeneca, tralokinumab
U.S. advisory panel recommends Prevnar 13 vaccine for elderly
Reuters
Thursday, August 14, 2014 - 7:58am
tags:
Pfizer, vaccines, Prevnar 13, FDA, advisory panels
InterMune buyout rumors resurface, with Roche, Sanofi on the short list
Fierce Biotech
Wednesday, August 13, 2014 - 5:29pm
tags:
InterMune, Roche, Sanofi, M&A
Merck Wins U.S. Approval of New Type of Sleeping Pill
Bloomberg
Wednesday, August 13, 2014 - 4:42pm
tags:
insomnia, Merck, FDA, Belsomra
Ackman says he remains committed to Valeant's bid for Allergan
Yahoo/Reuters
Wednesday, August 13, 2014 - 4:38pm
tags:
Bill Ackman, Valeant Pharmaceuticals, Allergan, M&A
Amgen Drops in After Hours on Failed Trial, Recall
Barron's
Wednesday, August 13, 2014 - 4:36pm
tags:
Amgen, Kyprolis, recalls, Aranesp, Multiple Myeloma
Researchers retract narcolepsy study linked to Glaxo's Pandemrix
Fierce Vaccines
Wednesday, August 13, 2014 - 4:32pm
tags:
GSK, Pandemrix, vaccines, narcolepsy
40% of American adults will develop type 2 diabetes in their lifetime
Medical News Today
Wednesday, August 13, 2014 - 4:28pm
tags:
diabetes
Pharma and physicians slam Sunshine Act for glitches, hassles and cloudy guidelines
Fierce Pharma Marketing
Wednesday, August 13, 2014 - 4:06pm
tags:
physicians, Physician Payment Sunshine Act
Dealpolitik: Allergan Must Tread Carefully as Showdown Looms
WSJ Online
Wednesday, August 13, 2014 - 11:04am
tags:
Allergan, M&A, Valeant Pharmaceuticals
BMS, Pfizer pull out all the stops to give Eliquis sales a Q2 jolt
Fierce Pharma Marketing
Wednesday, August 13, 2014 - 10:34am
tags:
Pfizer, Eliquis, bloodthinners, Bristol-Myers Squibb
When will Merck KGaA take the M&A plunge?
Fierce Biotech
Wednesday, August 13, 2014 - 10:22am
tags:
Merck KGaA, M&A
What the Market is Telling MannKind
24/7 Wall St
Wednesday, August 13, 2014 - 10:20am
tags:
MannKind, Afrezza, insulin, inhaled insulin, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.